A research team led by Hiroshima University and Tokyo University of Agriculture and Technology have proposed a neuroendocrine ...

Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen ...

Low dose of a hot flush medication (megestrol acetate) halts breast cancer growth, providing an economical way to improve ...

Women with these cancers are usually offered anti-oestrogens to deprive the cancer of oestrogen and inhibit its growth. But ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.

AMEERA-4: A preoperative window-of-opportunity (WOO) study to assess the pharmacodynamic (PD) activity of amcenestrant or letrozole in postmenopausal patients with ER+/HER2− primary breast cancer.

About three-quarters of breast cancers are ER-positive, meaning the tumours have many oestrogen receptors. These patients receive anti-oestrogen medication, which lowers oestrogen levels but can cause ...

When you have breast cancer, your doctor may remove some or all of the cancer tissue through a biopsy or surgery. Then, they’ll order tests of these cells to help them learn more about the cancer. One ...